Paul Korner - Nov 9, 2022 Form 4 Insider Report for AGILE THERAPEUTICS INC (AGRX)

Role
Sr. VP and CMO
Signature
/s/ Geoffrey P. Gilmore, Attorney-in-fact
Stock symbol
AGRX
Transactions as of
Nov 9, 2022
Transactions value $
$0
Form type
4
Date filed
11/14/2022, 03:35 PM
Previous filing
Jan 20, 2022
Next filing
Jun 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGRX Employee Stock Option (Right to Buy) Award $0 +10K $0.00 10K Nov 9, 2022 Common Stock 10K $0.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on November 9, 2022. 25% of the shares subject to the stock option vest on November 9, 2023, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on November 9, 2026.